Cytoreductive surgery plus intraperitoneal chemohyperthermia in patients with colorectal cancer at high risk for local-regional recurrence

Cancer Journal

Volumn 15, Issue 3, 2009, Pages 200-203

  Lefevre, Jeremie H ^a   Elias, Dominique M ^a  

^a INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Colorectal cancer; Cytoreductive surgery; Hyperthermic intraperitoneal chemotherapy; Peritoneal carcinomatosis

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; ANTINEOPLASTIC AGENT;

APPENDIX TUMOR; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER RELAPSE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CYTOREDUCTIVE SURGERY; DIAGNOSTIC VALUE; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; LENGTH OF STAY; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; MINIMAL RESIDUAL DISEASE; MORBIDITY; OVARY CANCER; OVARY METASTASIS; OVERALL SURVIVAL; PATIENT SELECTION; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECTUM CANCER; REOPERATION; REVIEW; SECOND LOOK SURGERY; SENSITIVITY AND SPECIFICITY; STOMACH CANCER; TUMOR PERFORATION; VISCERAL METASTASIS; ABDOMINAL SURGERY; COLORECTAL TUMOR; HYPERTHERMIC THERAPY; INFUSION; METASTASIS; MULTIMODALITY CANCER THERAPY; PATHOLOGY; PERITONEUM TUMOR; REGIONAL PERFUSION; TUMOR RECURRENCE;

ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, CANCER, REGIONAL PERFUSION; COLORECTAL NEOPLASMS; COMBINED MODALITY THERAPY; DIGESTIVE SYSTEM SURGICAL PROCEDURES; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; NEOPLASM RECURRENCE, LOCAL; PERITONEAL NEOPLASMS;

EID: 67651146462     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/PPO.0b013e3181a58f1d     Document Type: Review

References (48)

1. McArdle CS, McMillan DC, Hole DJ. The impact of blood loss, obstruction and perforation on survival in patients undergoing curative resection for colon cancer. Br J Surg. 2006;93:483-488.
2. Koppe MJ, Boerman OC, Oyen WJ, et al. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies. Ann Surg. 2006;243:212-222. (Pubitemid 43185440)
3. Verwaal VJ, van Ruth S, de Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol. 2003;21:3737-3743.
4. Jayne DG, Fook S, Loi C, et al. Peritoneal carcinomatosis from colorectal cancer. Br J Surg. 2002;89:1545-1550.
5. Sadeghi B, Arvieux C, Glehen O, et al. Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study. Cancer. 2000;88:358-363. (Pubitemid 30051820)
6. Chu DZ, Lang NP, Thompson C, et al. Peritoneal carcinomatosis in nongynecologic malignancy. A prospective study of prognostic factors. Cancer. 1989;63:364-367. (Pubitemid 19035034)
7. Elias D, Blot F, El Otmany A, et al. Curative treatment of peritoneal carcinomatosis arising from colorectal cancer by complete resection and intraperitoneal chemotherapy. Cancer. 2001;92:71-76. (Pubitemid 32623042)
8. Glehen O, Kwiatkowski F, Sugarbaker PH, et al. Cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for the management of peritoneal carcinomatosis from colorectal cancer: a multi-institutional study. J Clin Oncol. 2004;22:3284-3292. (Pubitemid 41103684)
9. Yan TD, Black D, Savady R, et al. Systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal carcinoma. J Clin Oncol. 2006;24:4011-4019. (Pubitemid 46630752)
10. Wangensteen OH. Cancer of the colon and rectum; with special reference to earlier recognition of alimentary tract malignancy; secondary delayed re-entry of the abdomen in patients exhibiting lymph node involvement; subtotal primary excision of the colon; operation in obstruction. Wis Med J. 1949;48:591-597.
11. Gilbertsen VA, Wangensteen OH. A summary of thirteen years' experience with the second look program. Surg Gynecol Obstet. 1962;114:438-442.
12. Gunderson LL, Sosin H, Levitt S. Extrapelvic colon - areas of failure in a reoperation series: implications for adjuvant therapy. Int J Radiat Oncol Biol Phys. 1985;11:731-741. (Pubitemid 15086896)
13. Zoetmulder FA. Cancer cell seeding during abdominal surgery: experimental studies. Cancer Treat Res. 1996;82:155-161.
14. Sweitzer KL, Nathanson SD, Nelson LT, et al. Irrigation does not dislodge or destroy tumor cells adherent to the tumor bed. J Surg Oncol. 1993;53:184-190.
15. Jacquet P, Elias D, Sugarbaker PH. [Tumor implantation in cicatrization sites following surgery for digestive cancers.] J Chir (Paris). 1996;133:175-182.
16. Willett C, Tepper JE, Cohen A, et al. Obstructive and perforative colonic carcinoma: patterns of failure. J Clin Oncol. 1985;3:379-384. (Pubitemid 15132006)
17. Slanetz CA Jr. The effect of inadvertent intraoperative perforation on survival and recurrence in colorectal cancer. Dis Colon Rectum. 1984;27:792-797.
18. Jestin P, Nilsson J, Heurgren M, et al. Emergency surgery for colonic cancer in a defined population. Br J Surg. 2005;92:94-100. (Pubitemid 40144201)
19. Yang SH, Lin JK, Lai CR, et al. Risk factors for peritoneal dissemination of colorectal cancer. J Surg Oncol. 2004;87:167-173. (Pubitemid 39167383)
20. Elias D, Lefevre JH, Chevalier J, et al. Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin. J Clin Oncol. 2009;27:681-685.
21. Verwaal VJ, van Ruth S, Witkamp A, et al. Long-term survival of peritoneal carcinomatosis of colorectal origin. Ann Surg Oncol. 2005;12:65-71. (Pubitemid 40486643)
22. Elias D, Raynard B, Farkhondeh F, et al. Peritoneal carcinomatosis of colorectal origin. Gastroenterol Clin Biol. 2006;30:1200-1204.
23. Sugarbaker PH, Schellinx ME, Chang D, et al. Peritoneal carcinomatosis from adenocarcinoma of the colon. World J Surg. 1996;20:585-591; discussion 592.
24. Elias D, Goere D, Di Pietrantonio D, et al. Results of systematic second-look surgery in patients at high risk of developing colorectal peritoneal carcinomatosis. Ann Surg. 2008;247:445-450.
25. Shen P, Hawksworth J, Lovato J, et al. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy with mitomycin C for peritoneal carcinomatosis from nonappendiceal colorectal carcinoma. Ann Surg Oncol. 2004;11:178-186. (Pubitemid 40486793)
26. Glehen O, Cotte E, Schreiber V, et al. Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin. Br J Surg. 2004;91:747-754. (Pubitemid 38746144)
27. Esquivel J, Sugarbaker PH. Second-look surgery in patients with peritoneal dissemination from appendiceal malignancy: analysis of prognostic factors in 98 patients. Ann Surg. 2001;234:198-205. (Pubitemid 32729426)
28. Mohamed F, Chang D, Sugarbaker PH. Third look surgery and beyond for appendiceal malignancy with peritoneal dissemination. J Surg Oncol. 2003;83:5-12; discussion 12-13. (Pubitemid 36528702)
29. Portilla AG, Sugarbaker PH, Chang D. Second-look surgery after cytoreduction and intraperitoneal chemotherapy for peritoneal carcinomatosis from colorectal cancer: analysis of prognostic features. World J Surg. 1999;23:23-29. (Pubitemid 28565555)
30. Elias D, Sideris L, Pocard M, et al. Efficacy of intraperitoneal chemohyperthermia with oxaliplatin in colorectal peritoneal carcinomatosis. Preliminary results in 24 patients. Ann Oncol. 2004;15:781-785. (Pubitemid 38714740)
31. Nakamura T, Tabuchi Y, Nakae S, et al. Serum carcinoembryonic antigen levels and proliferating cell nuclear antigen labeling index for patients with colorectal carcinoma. Correlation with tumor progression and survival. Cancer. 1996;77(8 Suppl):1741-1746. (Pubitemid 26111862)
32. Fletcher RH. Carcinoembryonic antigen. Ann Intern Med. 1986;104:66-73.
33. Wanebo JH, Stearns M, Schwartz MK. Use of CEA as an indicator of early recurrence and as a guide to a selected second-look procedure in patients with colorectal cancer. Ann Surg. 1978;188:481-493. (Pubitemid 9032424)
34. Martin EW Jr, Minton JP, Carey LC. CEA-directed second-look surgery in the asymptomatic patient after primary resection of colorectal carcinoma. Ann Surg. 1985;202:310-317.
35. Goldstein MJ, Mitchell EP. Carcinoembryonic antigen in the staging and follow-up of patients with colorectal cancer. Cancer Invest. 2005;23:338-351. (Pubitemid 41656973)
36. Mayer RJ, Garnick MB, Steele GD Jr, et al. Carcinoembryonic antigen (CEA) as a monitor of chemotherapy in disseminated colorectal cancer. Cancer. 1978;42(3 Suppl):1428-1433. (Pubitemid 9038269)
37. Hall NR, Finan PJ, Stephenson BM, et al. The role of CA-242 and CEA in surveillance following curative resection for colorectal cancer. Br J Cancer. 1994;70:549-553. (Pubitemid 24268563)
38. Sugarbaker PH, Gianola FJ, Dwyer A, et al. A simplified plan for follow-up of patients with colon and rectal cancer supported by prospective studies of laboratory and radiologic test results. Surgery. 1987;102:79-87. (Pubitemid 17102952)
39. Rocklin MS, Senagore AJ, Talbott TM. Role of carcinoembryonic antigen and liver function tests in the detection of recurrent colorectal carcinoma. Dis Colon Rectum. 1991;34:794-797.
40. McCall JL, Black RB, Rich CA, et al. The value of serum carcinoembryonic antigen in predicting recurrent disease following curative resection of colorectal cancer. Dis Colon Rectum. 1994;37:875-881.
41. Moertel CG, Fleming TR, Macdonald JS, et al. An evaluation of the carcinoembryonic antigen (CEA) test for monitoring patients with resected colon cancer. JAMA. 1993;270:943-947. (Pubitemid 23244732)
42. Bruinvels DJ, Stiggelbout AM, Kievit J, et al. Follow-up of patients with colorectal cancer. A meta-analysis. Ann Surg. 1994;219:174-182. (Pubitemid 24064074)
43. Berman JM, Cheung RJ, Weinberg DS. Surveillance after colorectal cancer resection. Lancet. 2000;355:395-399.
44. Elias D, Benizri E, Pocard M, et al. Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer. Eur J Surg Oncol. 2006;32:632-636. (Pubitemid 44064000)
45. Kianmanesh R, Scaringi S, Sabate JM, et al. Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases. Ann Surg. 2007;245:597-603. (Pubitemid 46555664)
46. Staab HJ, Anderer FA, Stumpf E, et al. Eighty-four potential second-look operations based on sequential carcinoembryonic antigen determinations and clinical investigations in patients with recurrent gastrointestinal cancer. Am J Surg. 1985;149:198-204. (Pubitemid 15174520)
47. Zhang C, Chen Y, Xue H, et al. Diagnostic value of FDG-PET in recurrent colorectal carcinoma: a meta-analysis. Int J Cancer. 2009;124:167-173.
48. Dromain C, Leboulleux S, Auperin A, et al. Staging of peritoneal carcinomatosis: enhanced CT vs. PET/CT. Abdom Imaging. 2008;33:87-93.